Teladoc Health, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Oct 28, 2026 (2 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 3, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Jul 30, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 30, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Jul 21, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 7, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| May 5, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Apr 8, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | — | 58% |
| Mar 26, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Mar 13, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Mar 10, 2026 | Deutsche Bank | upgrade | Hold → Buy | — | 57% |
| Mar 3, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Mar 3, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Feb 26, 2026 | Canaccord Genuity | maintain | Buy → Buy | $10 | 48% |
| Feb 26, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | $5.5 | 51% |
| Feb 26, 2026 | TD Cowen | maintain | Hold → Hold | $6 | 54% |
| Feb 26, 2026 | BMO Capital | maintain | Market Perform → Market Perform | $5 | 53% |
| Feb 26, 2026 | Piper Sandler | reiterate | Overweight → Overweight | $9 | 54% |
| Feb 26, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $6 | 54% |
| Feb 26, 2026 | Evercore ISI Group | maintain | In-Line → In-Line | $5 | 58% |
| Feb 26, 2026 | Stifel | maintain | Hold → Hold | $6 | 53% |
| Jan 9, 2026 | Citigroup | maintain | Neutral → Neutral | $9 | 54% |
| Dec 9, 2025 | Barclays | initiate | — → Equal-Weight | $8.5 | 53% |
| Nov 25, 2025 | B of A Securities | maintain | Neutral → Neutral | $8 | 53% |
| Nov 13, 2025 | BMO Capital | initiate | — → Market Perform | $8 | 53% |
| Oct 30, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $8 | 58% |
| Oct 21, 2025 | Citigroup | maintain | Neutral → Neutral | $10.5 | 54% |
| Oct 8, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $9 | 58% |
| Jul 25, 2025 | Mizuho | initiate | — → Neutral | $10 | 52% |
| Jul 9, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $8 | 58% |
| May 28, 2025 | B of A Securities | maintain | Neutral → Neutral | $7 | 53% |
| May 27, 2025 | Truist Securities | maintain | Hold → Hold | $9 | 54% |
| May 8, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $8 | 54% |
| May 1, 2025 | Canaccord Genuity | maintain | Buy → Buy | $12 | 48% |
| May 1, 2025 | Goldman Sachs | maintain | Buy → Buy | $10 | 54% |
| May 1, 2025 | Stifel | maintain | Hold → Hold | $8 | 53% |
| May 1, 2025 | Evercore ISI Group | maintain | In-Line → In-Line | $7 | 58% |
| May 1, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Apr 25, 2025 | Citigroup | maintain | Neutral → Neutral | $8.75 | 54% |
| Apr 21, 2025 | Jefferies | maintain | Hold → Hold | $8 | 52% |
| Apr 11, 2025 | B of A Securities | maintain | Neutral → Neutral | $8 | 53% |
| Mar 3, 2025 | Goldman Sachs | maintain | Buy → Buy | $13 | 54% |
| Feb 27, 2025 | Needham | reiterate | Hold → Hold | $0 | 50% |
| Feb 27, 2025 | Piper Sandler | maintain | Overweight → Overweight | $12 | 54% |
| Feb 18, 2025 | Goldman Sachs | maintain | Buy → Buy | $16 | 54% |
| Feb 12, 2025 | B of A Securities | maintain | Neutral → Neutral | $13.5 | 53% |
| Feb 6, 2025 | B of A Securities | maintain | Neutral → Neutral | $11.5 | 53% |
| Jan 24, 2025 | RBC Capital | maintain | Outperform → Outperform | $12 | 55% |
| Jan 24, 2025 | Oppenheimer | maintain | Outperform → Outperform | $12 | 52% |
| Dec 4, 2024 | Piper Sandler | reiterate | Overweight → Overweight | $13 | 54% |
| Nov 15, 2024 | Goldman Sachs | initiate | — → Buy | $14 | 54% |
No cross-platform signals in the last 90 days